INVEGA HAFYERA®
(paliperidone palmitate 6-month)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
INVEGA HAFYERA® (paliperidone palmitate 6-month)
Medical Information
Dosing of INVEGA HAFYERA - Alternative Injection Site
Last Updated: 06/05/2024
INVEGA HAFYERA is intended for gluteal intramuscular (IM) use only. Do not administer by any other route. Avoid inadvertent injection into a blood vessel.1 - Inject slowly, deep into the upper-outer quadrant of the gluteal muscle. Future injections should be alternated between the two gluteal muscles.1
- There is no information regarding the administration of INVEGA HAFYERA in any site other than the gluteal muscle.
CLINICAL DATA
- In the clinical study,2
INVEGA HAFYERA was administered in the dorsogluteal injection site only. Ventrogluteal injections were not permitted. - The junction of the posterior iliac crest and sacrum was palpated to draw an imaginary line to the greater trochanter of the femur. Injection was given in the upper-outer area bordered by this imaginary triangle.3
See Figure: Guidelines for Gluteal Intramuscular Injection of INVEGA HAFYERA.
- The junction of the posterior iliac crest and sacrum was palpated to draw an imaginary line to the greater trochanter of the femur. Injection was given in the upper-outer area bordered by this imaginary triangle.3
Literature Search
A literature search of MEDLINE®
References
| 1 | Data on File. Company Core Data Sheet - Paliperidone palmitate 6-month injection. Version 003. Janssen Research & Development, LLC; 2022. |
| 2 | |
| 3 |